Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling

Recent advances in reconstruction and analytical methods for signaling networks have spurred the development of large-scale models that incorporate fully functional and biologically relevant features. An extended reconstruction of the human Toll-like receptor signaling network is presented herein. This reconstruction contains an extensive complement of kinases, phosphatases, and other associated proteins that mediate the signaling cascade along with a delineation of their associated chemical reactions. A computational framework based on the methods of large-scale convex analysis was developed and applied to this network to characterize input–output relationships. The input–output relationships enabled significant modularization of the network into ten pathways. The analysis identified potential candidates for inhibitory mediation of TLR signaling with respect to their specificity and potency. Subsequently, we were able to identify eight novel inhibition targets through constraint-based modeling methods. The results of this study are expected to yield meaningful avenues for further research in the task of mediating the Toll-like receptor signaling network and its effects.

[1]  W. Kolch,et al.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. , 2001, Molecular and cellular biology.

[2]  Ronan M. T. Fleming,et al.  Genome-Scale Reconstruction of Escherichia coli's Transcriptional and Translational Machinery: A Knowledge Base, Its Mathematical Formulation, and Its Functional Characterization , 2009, PLoS Comput. Biol..

[3]  Harald Stenmark,et al.  Role of Rab5 in the Recruitment of hVps34/p150 to the Early Endosome , 2002, Traffic.

[4]  H. Qian,et al.  Energy balance for analysis of complex metabolic networks. , 2002, Biophysical journal.

[5]  Michael Gale,et al.  Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection , 2008, Journal of Virology.

[6]  B. Palsson Systems Biology: Properties of Reconstructed Networks , 2006 .

[7]  Robert Urbanczik,et al.  An improved algorithm for stoichiometric network analysis: theory and applications , 2005, Bioinform..

[8]  Nan Xiao,et al.  Integrating metabolic, transcriptional regulatory and signal transduction models in Escherichia coli , 2008, Bioinform..

[9]  F. Liew,et al.  Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.

[10]  F. Re,et al.  Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness* , 2002, The Journal of Biological Chemistry.

[11]  Bernhard O. Palsson,et al.  Estimation of the number of extreme pathways for metabolic networks , 2007, BMC Bioinformatics.

[12]  B. Beutler,et al.  Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.

[13]  M Locati,et al.  Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.

[14]  B. Palsson,et al.  Candidate Metabolic Network States in Human Mitochondria , 2005, Journal of Biological Chemistry.

[15]  Gregory D. Longmore,et al.  The LIM Protein Ajuba Influences Interleukin-1-Induced NF-κB Activation by Affecting the Assembly and Activity of the Protein Kinase Cζ/p62/TRAF6 Signaling Complex , 2005, Molecular and Cellular Biology.

[16]  Eun Jeoung Lee,et al.  Inhibition of mitogen-activated kinase kinase kinase 3 activity through phosphorylation by the serum- and glucocorticoid-induced kinase 1. , 2003, Journal of biochemistry.

[17]  Hideo Negishi,et al.  IRF-7 is the master regulator of type-I interferon-dependent immune responses , 2005, Nature.

[18]  K. Wirtz,et al.  Phosphatidic acid is a specific activator of phosphatidylinositol-4-phosphate kinase. , 1992, The Journal of biological chemistry.

[19]  S. Akira,et al.  Toll-like receptor function and signaling. , 2006, The Journal of allergy and clinical immunology.

[20]  Adam M. Feist,et al.  Reconstruction of biochemical networks in microorganisms , 2009, Nature Reviews Microbiology.

[21]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[22]  Kenneth J. Kauffman,et al.  Advances in flux balance analysis. , 2003, Current opinion in biotechnology.

[23]  C. Coban,et al.  Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6 , 2004, Nature Immunology.

[24]  Jun Dong,et al.  Understanding network concepts in modules , 2007, BMC Systems Biology.

[25]  H. Kitano,et al.  A comprehensive map of the toll-like receptor signaling network , 2006, Molecular systems biology.

[26]  S. Akira,et al.  TLR signaling. , 2006, Cell death and differentiation.

[27]  W. Liao,et al.  The IL-1 receptor accessory protein is essential for PI 3-kinase recruitment and activation. , 2004, Biochemical and biophysical research communications.

[28]  Bernhard Ø Palsson,et al.  Candidate states of Helicobacter pylori's genome-scale metabolic network upon application of "loop law" thermodynamic constraints. , 2006, Biophysical journal.

[29]  R. Gazzinelli,et al.  Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria , 2008, Seminars in Immunopathology.

[30]  Phillip T. Hawkins,et al.  Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B , 1998, Current Biology.

[31]  B. Palsson,et al.  Genome-scale models of microbial cells: evaluating the consequences of constraints , 2004, Nature Reviews Microbiology.

[32]  Hla Y Win,et al.  Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival. , 2008, Cancer letters.

[33]  Madhukar S. Dasika,et al.  A computational framework for the topological analysis and targeted disruption of signal transduction networks. , 2006, Biophysical journal.

[34]  An-Ping Zeng,et al.  The Connectivity Structure, Giant Strong Component and Centrality of Metabolic Networks , 2003, Bioinform..

[35]  H. Nakano,et al.  The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.

[36]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[37]  Matthew S. Hayden,et al.  New regulators of NF-κB in inflammation , 2008, Nature Reviews Immunology.

[38]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[39]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[40]  Bernhard O. Palsson,et al.  Matrix Formalism to Describe Functional States of Transcriptional Regulatory Systems , 2006, PLoS Comput. Biol..

[41]  K. Griendling,et al.  Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. , 2007, Trends in cardiovascular medicine.

[42]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[43]  Bernhard O. Palsson,et al.  Bringing Genomes to Life: The Use of Genome-Scale In Silico Models , 2007 .

[44]  Grazia Gallo,et al.  Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.

[45]  B. Palsson,et al.  Expanded Metabolic Reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an In Silico Genome-Scale Characterization of Single- and Double-Deletion Mutants , 2005, Journal of bacteriology.

[46]  C. Elbim,et al.  Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. , 2005, Archivum immunologiae et therapiae experimentalis.

[47]  Uri Alon,et al.  Input–output robustness in simple bacterial signaling systems , 2007, Proceedings of the National Academy of Sciences.

[48]  B. Beutler,et al.  TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy. , 2006, Current pharmaceutical design.

[49]  M. Sajan,et al.  Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. , 2001, Biochemistry.

[50]  Jason A. Papin,et al.  The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis. , 2004, Biophysical journal.

[51]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.

[52]  Makoto Sawada,et al.  Stimulus-dependent Regulation of the Phagocyte NADPH Oxidase by a VAV1, Rac1, and PAK1 Signaling Axis* , 2008, Journal of Biological Chemistry.

[53]  Uri Alon,et al.  An Introduction to Systems Biology , 2006 .

[54]  F. Meyskens,et al.  UC Irvine UC Irvine Previously Published Works Title Reactive oxygen species : a breath of life or death ? , 2007 .

[55]  Erwin P. Gianchandani,et al.  Dynamic Analysis of Integrated Signaling, Metabolic, and Regulatory Networks , 2008, PLoS Comput. Biol..

[56]  B. Palsson,et al.  Towards multidimensional genome annotation , 2006, Nature Reviews Genetics.

[57]  T. Akazawa,et al.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.

[58]  B. Palsson,et al.  Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use , 1994, Bio/Technology.

[59]  Ronan M. T. Fleming,et al.  Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.

[60]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[61]  Martin Braddock,et al.  Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention , 2004, Nature Reviews Drug Discovery.

[62]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[63]  N. Perkins Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.

[64]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[65]  D. Boraschi,et al.  The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.

[66]  Ruslan Medzhitov,et al.  Toll-like receptors and acquired immunity. , 2004, Seminars in immunology.

[67]  Kyongbum Lee,et al.  BIOINFORMATICS ORIGINAL PAPER doi:10.1093/bioinformatics/btm374 Systems biology Modular decomposition of metabolic reaction networks based on flux analysis and pathway projection , 2022 .

[68]  Gerene M Denning,et al.  Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease. , 2006, Current pharmaceutical design.

[69]  J Tuomilehto,et al.  Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis , 2007, Annals of the rheumatic diseases.

[70]  Guo-Ping Zhou,et al.  Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.

[71]  Bernhard O. Palsson,et al.  Metabolic flux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions , 2000, BMC Bioinformatics.

[72]  J. Banchereau,et al.  Pyogenic Bacterial Infections in Humans with MyD88 Deficiency , 2003, Science.

[73]  P. Tobias,et al.  Toll-like receptors and atherosclerosis , 2006, Immunologic research.

[74]  R. Maccioni,et al.  Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. , 2008, Archives of medical research.

[75]  T. Muta,et al.  Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. , 2001, European journal of biochemistry.

[76]  P. Hertzog,et al.  Toll-like receptor signalling and the clinical benefits that lie within , 2007, Inflammation Research.

[77]  H. Ichijo,et al.  ASK Family Proteins in Stress Response and Disease , 2007, Molecular biotechnology.

[78]  L. O’Neill,et al.  How Toll-like receptors signal: what we know and what we don't know. , 2006, Current opinion in immunology.